» Articles » PMID: 19891844

Preimplantation Genetic Diagnosis for Gender Selection in the USA

Overview
Publisher Elsevier
Date 2009 Nov 7
PMID 19891844
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Preimplantation genetic diagnosis (PGD) for gender selection for non-medical reasons has been considered an unethical procedure by several authors and agencies in the Western society on the basis that it could disrupt the sex ratio, that it discriminates against women and that it leads to disposal of normal embryos of the non-desired gender. In this study, the analysis of a large series of PGD procedures for gender selection from a wide geographical area in the USA shows that, in general, there is no deviation in preference towards any specific gender except for a preference of males in some ethnic populations of Chinese, Indian and Middle Eastern origin that represent a small percentage of the US population. In cases where only normal embryos of the non-desired gender are available, 45.5% of the couples elect to cancel the transfer, while 54.5% of them are open to have embryos transferred of the non-desired gender, this fact being strongly linked to cultural and ethnic background of the parents. In addition this study adds some evidence to the proposition that, in couples with previous children of a given gender, there is no biological predisposition towards producing embryos of that same gender. Based on these facts, it seems that objections to gender selection formulated by ethics committees and scientific societies are not well founded.

Citing Articles

Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing.

Gallois H, Ravitsky V, Roy M, Laberge A Eur J Hum Genet. 2024; 33(2):167-175.

PMID: 39462080 PMC: 11840150. DOI: 10.1038/s41431-024-01714-8.


Pre-Implantation Gender Selection: Family Balancing in Jordan.

Sindiani A, Zayed F, Alshdaifat E, Rawashdeh H, Al-Woshah W, Zayed N Risk Manag Healthc Policy. 2021; 14:2797-2801.

PMID: 34239335 PMC: 8259936. DOI: 10.2147/RMHP.S306124.


What Israeli policy can teach us about elective sex selection.

Leiter G Isr J Health Policy Res. 2014; 3(1):42.

PMID: 25544884 PMC: 4277833. DOI: 10.1186/2045-4015-3-42.


Chromosome-specific DNA repeats: rapid identification in silico and validation using fluorescence in situ hybridization.

Hsu J, Zeng H, Lemke K, Polyzos A, Weier J, Wang M Int J Mol Sci. 2013; 14(1):57-71.

PMID: 23344021 PMC: 3565251. DOI: 10.3390/ijms14010057.